Pharma Companies Invest In US While India Still Depends On China For APIs
By TodayTelugu Desk1 min read0 views
“For decades, India built its reputation as the “pharmacy of the world” by manufacturing low-cost generic medicines that reached millions across Africa, Latin America, and Asia. But now, the industry appears determined to move beyond the image of being merely a low-cost generic supplier,” said Ravi Uday Bhaskar, former Director General of Pharmexcil
Related News
Comments
Login to leave a comment











